Tetraphase Pharmaceuticals, Inc. (TTPH) Stock Ratings

View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:

Not Rated

No Current Ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks

Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
gasparvili gasparvili 05/16/2018 3 months $3.87 $3.09 -20.16% -20 Ended
Comments: It will be evaluated for intraabdominal infection, for which it did great. The cUTI is hard to treat
Kareim M. Abbouda Kareim M. Abbouda 02/14/2018 3 months $2.15 $3.70 +72.09% 72 Ended
Comments: New Support Being Created | Despite failure at drug trials, still ranked "strong buy"
renee.etiennecb renee.etiennecb 02/07/2018 3 months $5.58 $3.64 -34.77% -34 Ended
Chrisyahahha Chrisyahahha 01/07/2016 3 months $7.82 $4.76 -39.13% 39 Ended
ChKi ChKi 06/03/2015 3 months $42.27 $43.41 +2.7% 2 Ended
Comments: Bullish because of new IGNITE 2 data in July!!!
fabdalpiero fabdalpiero 05/06/2015 3 months $36.89 $47.62 +29.09% 29 Ended
Comments: buy on average with rising target by the end of the period.

Neither NASDAQ, Inc. nor any of its affiliates (collectively "NASDAQ") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ. Investors should undertake their own due diligence and carefully evaluate companies before investing.